midazolam has been researched along with Headache Disorders in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Headache Disorders: Various conditions with the symptom of HEADACHE. Headache disorders are classified into major groups, such as PRIMARY HEADACHE DISORDERS (based on characteristics of their headache symptoms) and SECONDARY HEADACHE DISORDERS (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "On the basis of a small number of case studies, IV propofol has been advocated for the treatment of chronic daily headache (CDH)." | 9.14 | The effect of single-dose propofol injection on pain and quality of life in chronic daily headache: a randomized, double-blind, controlled trial. ( Dick, BD; Gray, DP; Jamieson-Lega, KI; Rashiq, S; Simmonds, MK; Sobolev, IA; Stewart, BJ, 2009) |
| "On the basis of a small number of case studies, IV propofol has been advocated for the treatment of chronic daily headache (CDH)." | 5.14 | The effect of single-dose propofol injection on pain and quality of life in chronic daily headache: a randomized, double-blind, controlled trial. ( Dick, BD; Gray, DP; Jamieson-Lega, KI; Rashiq, S; Simmonds, MK; Sobolev, IA; Stewart, BJ, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simmonds, MK | 1 |
| Rashiq, S | 1 |
| Sobolev, IA | 1 |
| Dick, BD | 1 |
| Gray, DP | 1 |
| Stewart, BJ | 1 |
| Jamieson-Lega, KI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Single-dose Propofol Injection on Pain and Quality of Life in Chronic Daily Headache: a Randomized Double-blind Controlled Trial[NCT00228267] | Phase 2 | 28 participants (Anticipated) | Interventional | 2004-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for midazolam and Headache Disorders
| Article | Year |
|---|---|
The effect of single-dose propofol injection on pain and quality of life in chronic daily headache: a randomized, double-blind, controlled trial.
Topics: Adult; Analgesics; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Female; | 2009 |